Role of long noncoding RNA taurine‐upregulated gene 1 in cancers

Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 ( TUG1 ) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by speci...

Full description

Saved in:
Bibliographic Details
Published in:Molecular medicine (Cambridge, Mass.) Vol. 27; no. 1; pp. 51 - 17
Main Authors: Da, Miao, Zhuang, Jing, Zhou, Yani, Qi, Quan, Han, Shuwen
Format: Journal Article
Language:English
Published: London BioMed Central 26.05.2021
Springer Nature B.V
BMC
Subjects:
Angiogenesis
Animals
Apoptosis
Apoptosis - genetics
Biomarker
Biomarkers, Tumor
Biomedical and Life Sciences
Biomedicine
Bladder cancer
Bone cancer
Breast cancer
Cancer
Cell Cycle
Cell division
Cell growth
Cell Line, Tumor
Cell Movement
Cell Proliferation
Chemotherapy
Competitive endogenous RNA (ceRNA)
Cyclin-dependent kinases
Disease Susceptibility
Drug resistance
Epigenetics
Gene Expression Regulation, Neoplastic - drug effects
Humans
Kidney cancer
Kinases
Long non-coding RNA (lncRNA)
Lung cancer
Metastasis
MicroRNAs
Molecular Medicine
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Neoplasms - therapy
Neovascularization, Pathologic - genetics
Neovascularization, Pathologic - metabolism
Pancreatic cancer
Prostate cancer
Review
RNA, Long Noncoding - genetics
Signal Transduction
Taurine‐upregulated gene 1 (TUG1)
Vascular endothelial growth factor
)
Biomarker
Competitive endogenous RNA (ceRNA)
Long non-coding RNA (lncRNA)
Taurine‐upregulated gene 1
Cancer
Taurine‐upregulated gene 1 (TUG1)
ISSN:1076-1551, 1528-3658, 1528-3658
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Long non-coding RNAs (lncRNAs) are a group of non-protein coding RNAs with a length of more than 200 bp. The lncRNA taurine up-regulated gene 1 ( TUG1 ) is abnormally expressed in many human malignant cancers, where it acts as a competitive endogenous RNA (ceRNA), regulating gene expression by specifically sponging its corresponding microRNAs. In the present review, we summarised the current understanding of the role of lncRNA TUG1 in cancer cell proliferation, metastasis, angiogenesis, chemotherapeutic drug resistance, radiosensitivity, cell regulation, and cell glycolysis, as well as highlighting its potential application as a clinical biomarker or therapeutic target for malignant cancer. This review provides the basis for new research directions for lncRNA TUG1 in cancer prevention, diagnosis, and treatment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1076-1551
1528-3658
1528-3658
DOI:10.1186/s10020-021-00312-4